Endologix Inc. to Participate in Several Upcoming Investor Conferences
11/6/2012 9:22:05 AM
IRVINE, Calif., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to participate in five upcoming investor conferences in November and December. The first conference is the Stephens Fall Investment Conference in New York. The Stephens conference will allow institutional investors to meet with Endologix but does not include a formal presentation.